Clinical Edge Journal Scan

Presence of crystals in synovial fluid tied with higher disease burden in PsA


 

Key clinical point: The prevalence of crystals in the synovial fluid was higher in patients with psoriatic arthritis (PsA) than in those with gonarthrosis and indicated increased disease activity and declining physical abilities in patients with PsA.

Major finding: Synovial fluid crystals were present in a significantly higher proportion of patients with PsA vs. gonarthrosis (23.7% vs. 0%; P < .001), with the presence of crystals being associated with an increased odds of severe pain (odds ratio [OR] 157.25), high disease activity (OR 15.96), and severe disability (OR 13.60; all P < .001).

Study details: Findings are from a retrospective case-control study including 156 patients with PsA and 50 patients with gonarthrosis.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Geneva-Popova M et al. Assessment of crystals in the synovial fluid of psoriatic arthritis patients in relation to disease activity. Diagnostics (Basel). 2022;12(5):1260 (May 18). Doi: 10.3390/diagnostics12051260

Recommended Reading

Serum brodalumab levels linked with treatment outcomes in patients with psoriasis
Psoriatic Arthritis ICYMI
Izokibep improves multiple psoriatic arthritis symptoms in phase 2 study
Psoriatic Arthritis ICYMI
Biologics, Women, and Pregnancy: What’s Known?
Psoriatic Arthritis ICYMI
Psoriatic Arthritis Treatment Basics
Psoriatic Arthritis ICYMI
Bimekizumab calms psoriatic arthritis in phase 3 ‘BE’ trials
Psoriatic Arthritis ICYMI
Enthesitis resolves regardless of medication used in PsA
Psoriatic Arthritis ICYMI
Upadacitinib offers effective disease control in PsA
Psoriatic Arthritis ICYMI
Real-world study confirms benefits of golimumab on work productivity and QoL in PsA
Psoriatic Arthritis ICYMI
Identifying clinical characteristics of difficult-to-treat PsA
Psoriatic Arthritis ICYMI
Current psoriatic lesions or a personal history of psoriasis correlates with PsA disease activity
Psoriatic Arthritis ICYMI